| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,139,423 | 1,299,407 | ||
| Accounts receivable, net | 63,212 | 390,013 | ||
| Inventory | 757,500 | 248,519 | ||
| Prepaid expense | 34,864 | 47,334 | ||
| Overpayment to related parties | 0 | 0 | ||
| Total current assets | 1,994,999 | 1,985,273 | ||
| Intangible assets | 72,101 | 72,101 | ||
| Total assets | 2,067,100 | 2,057,374 | ||
| Accounts payable | 10,165 | 16,636 | ||
| Due to related parties-Related Party | 228,298 | 47,837 | ||
| Accrued expenses | 6,686 | 24,500 | ||
| Deferred revenue | 110,991 | 248,659 | ||
| Total current liabilities | 356,140 | 337,632 | ||
| Series a convertible preferred stock, 1,000,000 designated, 140,000 shares issued and outstanding at september 30, 2025 and december 31, 2024 | 14 | 14 | ||
| Common stock 0.0001 par value, 250,000,000 shares authorized 10,979,055 shares issued and outstanding at september 30, 2025 and december 31, 2024 | 1,098 | 4,391 | ||
| Additional paid-in capital | 1,175,211 | 1,171,918 | ||
| Accumulated earnings (deficit) | 534,637 | 543,419 | ||
| Total stockholders' equity (deficit) | 1,710,960 | 1,719,742 | ||
| Total liabilities and stockholders' equity (deficit) | 2,067,100 | 2,057,374 | ||
BioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. (BHIC)